Sinopharm
1099.HK
#2313
Rank
โ‚น762.69 B
Marketcap
โ‚น244.40
Share price
-2.33%
Change (1 day)
15.29%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.291 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.291 Trillion. In 2024 the company made a revenue of โ‚น7.291 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.683 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.291 T-5.1%
2023โ‚น7.683 T5.42%
2022โ‚น7.288 T-2.1%
2021โ‚น7.444 T16.85%
2020โ‚น6.370 T14.95%
2019โ‚น5.542 T21.52%
2018โ‚น4.560 T5.93%
2017โ‚น4.305 T27.22%
2016โ‚น3.384 T5.37%
2015โ‚น3.211 T9.14%
2014โ‚น2.942 T17.22%
2013โ‚น2.510 T25.94%
2012โ‚น1.993 T34.61%
2011โ‚น1.480 T55.34%
2010โ‚น953.22 B35.79%
2009โ‚น701.99 B37.56%
2008โ‚น510.33 B31.43%
2007โ‚น388.30 B40.26%
2006โ‚น276.83 B